Evaluation of potential gender-related differences in behavioral and cognitive alterations following pilocarpine-induced status epilepticus in C57BL/6 mice

Physiology and Behavior

Volumn 143, Issue , 2015, Pages 142-150

  Oliveira, Clarissa Vasconcelos de ^a   Grigoletto, Jéssica ^a   Funck, Vinícius Rafael ^a   Ribeiro, Leandro Rodrigo ^a   Royes, Luiz Fernando Freire ^a   Fighera, Michele Rechia ^a   Furian, Ana Flávia ^a   Oliveira, Mauro Schneider ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Behavioral abnormalities; Gender; Status epilepticus; Temporal lobe epilepsy

Indexed keywords

PILOCARPINE; ANTICONVULSIVE AGENT; DIAZEPAM; MUSCARINIC AGENT;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; EPILEPTIC STATE; FEMALE; FORCED SWIM TEST; MALE; MAZE TEST; MEMORY; MOTOR COORDINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECOGNITION; ROTAROD TEST; SEX DIFFERENCE; TASTE PREFERENCE; AGE; ANALYSIS OF VARIANCE; ANIMAL; BODY EQUILIBRIUM; C57BL MOUSE; CHEMICALLY INDUCED; COGNITION DISORDERS; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; FOOD PREFERENCE; MENTAL DISORDERS; MOTOR ACTIVITY; PSYCHOLOGY; PSYCHOMOTOR DISORDERS; SEXUAL DEVELOPMENT; SWIMMING;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; COGNITION DISORDERS; DIAZEPAM; DISEASE MODELS, ANIMAL; FEMALE; FOOD PREFERENCES; MALE; MAZE LEARNING; MENTAL DISORDERS; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MUSCARINIC AGONISTS; PILOCARPINE; POSTURAL BALANCE; PSYCHOMOTOR DISORDERS; RECOGNITION (PSYCHOLOGY); SEX CHARACTERISTICS; STATUS EPILEPTICUS; SWIMMING;

EID: 84924175433     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2015.03.004     Document Type: Article

References (36)

1. Rowley S., Patel M. Mitochondrial involvement and oxidative stress in temporal lobe epilepsy. Free Radic. Biol. Med. 2013, 62:121-131.
2. Wieser H.G. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 2004, 45:695-714.
3. Murphy G.G. Spatial learning and memory - what's TLE got to do with it?. Epilepsy Curr. 2013, 13:26-29.
4. Curia G., Longo D., Biagini G., Jones R.S., Avoli M. The pilocarpine model of temporal lobe epilepsy. J. Neurosci. Methods 2008, 172:143-157.
5. Buckmaster P.S., Haney M.M. Factors affecting outcomes of pilocarpine treatment in a mouse model of temporal lobe epilepsy. Epilepsy Res. 2012, 102:153-159.
6. Muller C.J., Groticke I., Hoffmann K., Schughart K., Loscher W. Differences in sensitivity to the convulsant pilocarpine in substrains and sublines of C57BL/6 mice. Genes Brain Behav. 2009, 8:481-492.
7. Borges K., Gearing M., McDermott D.L., Smith A.B., Almonte A.G., Wainer B.H., et al. Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp. Neurol. 2003, 182:21-34.
8. Muller C.J., Groticke I., Bankstahl M., Loscher W. Behavioral and cognitive alterations, spontaneous seizures, and neuropathology developing after a pilocarpine-induced status epilepticus in C57BL/6 mice. Exp. Neurol. 2009, 219:284-297.
9. Bankstahl M., Muller C.J., Wilk E., Schughart K., Loscher W. Generation and characterization of pilocarpine-sensitive C57BL/6 mice as a model of temporal lobe epilepsy. Behav. Brain Res. 2012, 230:182-191.
10. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32:281-294.
11. Mazzuferi M., Kumar G., Rospo C., Kaminski R.M. Rapid epileptogenesis in the mouse pilocarpine model: video-EEG, pharmacokinetic and histopathological characterization. Exp. Neurol. 2012, 238:156-167.
12. Groticke I., Hoffmann K., Loscher W. Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice. Exp. Neurol. 2007, 207:329-349.
13. Rubin M.A., Berlese D.B., Stiegemeier J.A., Volkweis M.A., Oliveira D.M., dos Santos T.L., et al. Intra-amygdala administration of polyamines modulates fear conditioning in rats. J. Neurosci. 2004, 24:2328-2334.
14. Bevins R.A., Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat. Protoc. 2006, 1:1306-1311.
15. Irintchev A., Simova O., Eberhardt K.A., Morellini F., Schachner M. Impacts of lesion severity and tyrosine kinase receptor B deficiency on functional outcome of femoral nerve injury assessed by a novel single-frame motion analysis in mice. Eur. J. Neurosci. 2005, 22:802-808.
16. Wahlsten D., Metten P., Phillips T.J., Boehm S.L., Burkhart-Kasch S., Dorow J., et al. Different data from different labs: lessons from studies of gene-environment interaction. J. Neurobiol. 2003, 54:283-311.
17. Mazarati A., Siddarth P., Baldwin R.A., Shin D., Caplan R., Sankar R. Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain 2008, 131:2071-2083.
18. Oliveira M.S., Furian A.F., Fighera M.R., Fiorenza N.G., Ferreira J., Rubin M.A., et al. The involvement of the polyamines binding sites at the NMDA receptor in creatine-induced spatial learning enhancement. Behav. Brain Res. 2008, 187:200-204.
19. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 2002, 22:1858-1867.
20. Sunal R., Gumusel B., Kayaalp S.O. Effect of changes in swimming area on results of "behavioral despair test". Pharmacol. Biochem. Behav. 1994, 49:891-896.
21. Iniguez C., Gayoso M.J., Carreres J. A versatile and simple method for staining nervous tissue using Giemsa dye. J. Neurosci. Methods 1985, 13:77-86.
22. Hermann B., Seidenberg M., Jones J. The neurobehavioural comorbidities of epilepsy: can a natural history be developed?. Lancet Neurol. 2008, 7:151-160.
23. Swinkels W.A., Kuyk J., van Dyck R., Spinhoven P. Psychiatric comorbidity in epilepsy. Epilepsy Behav. 2005, 7:37-50.
24. Harden C.L. The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment. Neurology 2002, 59:S48-S55.
25. LaFrance W.C., Kanner A.M., Hermann B. Psychiatric comorbidities in epilepsy. Int. Rev. Neurobiol. 2008, 83:347-383.
26. Palanza P. Animal models of anxiety and depression: how are females different?. Neurosci. Biobehav. Rev. 2001, 25:219-233.
27. Simon P., Dupuis R., Costentin J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav. Brain Res. 1994, 61:59-64.
28. Crawley J.N., Belknap J.K., Collins A., Crabbe J.C., Frankel W., Henderson N., et al. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) 1997, 132:107-124.
29. Barnes C.A. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J. Comp. Physiol. Psychol. 1979, 93:74-104.
30. Goddyn H., Leo S., Meert T., D'Hooge R. Differences in behavioural test battery performance between mice with hippocampal and cerebellar lesions. Behav. Brain Res. 2006, 173:138-147.
31. Keedwell P.A., Andrew C., Williams S.C., Brammer M.J., Phillips M.L. The neural correlates of anhedonia in major depressive disorder. Biol. Psychiatry 2005, 58:843-853.
32. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev. 2005, 29:571-625.
33. Tang F.R., Loke W.K. Cyto-, axo- and dendro-architectonic changes of neurons in the limbic system in the mouse pilocarpine model of temporal lobe epilepsy. Epilepsy Res. 2010, 89:43-51.
34. Turski W.A., Cavalheiro E.A., Bortolotto Z.A., Mello L.M., Schwarz M., Turski L. Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res. 1984, 321:237-253.
35. Ravizza T., Gagliardi B., Noe F., Boer K., Aronica E., Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 2008, 29:142-160.
36. Avchalumov Y., Kirschstein T., Kohling R. Altered physiology and pharmacology in the corticostriatal system in a model of temporal lobe epilepsy. Epilepsia 2011, 52:151-157.